Full Text View
Tabular View
No Study Results Posted
Related Studies
Study Assessing the Interaction of Pantoprazole With Cladribine in Subjects With Multiple Sclerosis
This study has been completed.
Study NCT00938366   Information provided by Merck KGaA

First Received on July 9, 2009.   Last Updated on January 10, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Multiple Sclerosis
Additional conditions recognized in this trial
Sclerosis
More general conditions related to this trial
Autoimmune Diseases
Autoimmune Diseases of the Nervous System
Demyelinating Autoimmune Diseases, CNS
Demyelinating Diseases
Immune System Diseases
Nervous System Diseases
Pathologic Processes
Interventions listed in this trial
Cladribine
Cladribine and Pantoprazole
Additional drug interventions recognized in this trial
Pantoprazole
Proton Pump Inhibitors
More general drug interventions related to this trial
Anti-Ulcer Agents
Antineoplastic Agents
Enzyme Inhibitors
Gastrointestinal Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Merck KGaA
Merck Serono S.A., Geneva


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services